Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

Good point. Earlier in the fall when the trials were being planned the Covid numbers were fluctuating at different geographic sites. Unfortunately the numbers of Covid cases now seems to be increasing everywhere,here and abroad.

My guess is the geographic diversity of the sites was to protect from a down turn in the number of cases at several sites which would impact the number of cases eligible for study.

In retrospect it appears that precaution is proving to be unnecessary.

The increase in the number of cases does reinforce the need for better treatments and a better antiviral.

Hopefully Brilacidin will be effective.

GLTA,Farrell